Abstract
The first stereocontrolled synthesis of the C(1)-C(13) fragment of cytotoxic macrolides dolabelides is reported. The C(3), C(7), C(9) and C(11) hydroxyl-bearing stereocenters were installed using ruthenium-mediated asymmetric hydrogenation reactions of the adequate β-keto esters and β-hydroxy ketone.
Key words
asymmetric catalysis - hydrogenation - ruthenium - total synthesis - natural products
References
1 Ojika M.
Nagoya T.
Shibata T.
Yamada K.
Tetrahedron Lett.
1995,
36:
7491
2 Suenaga K.
Nagoya T.
Shibata T.
Kigoshi H.
Yamada K.
J. Nat. Prod.
1997,
60:
155
3 Phansavath P.
Duprat de Paule S.
Ratovelomanana-Vidal V.
Genêt J.-P.
Eur. J. Org. Chem.
2000,
3903
4 Lavergne D.
Mordant C.
Ratovelomanana-Vidal V.
Genêt J.-P.
Org. Lett.
2001,
3:
1909
5 Labeeuw O.
Phansavath P.
Genêt J.-P.
Tetrahedron: Asymmetry
2004,
15:
1899
6a Duprat de Paule S.
Jeulin S.
Ratovelomanana-Vidal V.
Genêt J.-P.
Champion N.
Dellis P.
Tetrahedron Lett.
2003,
44:
823
6b Duprat de Paule S.
Jeulin S.
Ratovelomanana-Vidal V.
Genêt J.-P.
Champion N.
Dellis P.
Eur. J. Org. Chem.
2003,
1931
6c Both antipodes of SYNPHOS® {[2,3,2′,3′-tetrahydro-5,5′-bi(1,4-benzodioxin)-6,6′-diyl]bis(diphenylphosphane)} are commercially available from Strem Chemicals.
7 Grimaud L.
de Mesmay R.
Prunet J.
Org. Lett.
2002,
4:
419
8 Desroy N.
Le Roux R.
Phansavath P.
Chiummiento L.
Bonini C.
Genêt J.-P.
Tetrahedron Lett.
2003,
44:
1763
9 Schmidt DR.
Park PK.
Leighton JL.
Org. Lett.
2003,
5:
3535
10a Genêt J.-P. In
Reductions in Organic Synthesis
Magid A.
ACS Symposium Series 641, American Chemical Society;
Washington DC:
1996.
p.31-51
10b Genêt J.-P.
Acc. Chem. Res.
2003,
36:
908
11 Noyori R.
Acta Chem. Scand.
1996,
50:
380
12 Walkup RD.
Kane RR.
Boatman PD.
Cunningham RT.
Tetrahedron Lett.
1990,
31:
7587
13 Rathke MW.
Lindert A.
J. Am. Chem. Soc.
1971,
93:
2318
14 Genêt J.-P.
Pinel C.
Ratovelomanana-Vidal V.
Mallart S.
Caño de Andrade MC.
Laffite J.-A.
Tetrahedron: Asymmetry
1994,
5:
665
15 Genêt J.-P.
Ratovelomanana-Vidal V.
J. Organomet. Chem.
1998,
567:
163
16 Fráter G.
Helv. Chim. Acta
1979,
62:
2825
17 Seebach D.
Wasmuth D.
Helv. Chim. Acta
1980,
63:
197
18 Paterson I.
Smith JD.
Ward RA.
Tetrahedron
1995,
51:
9413
19 Claffey MM.
Hayes CJ.
Heathcock CH.
J. Org. Chem.
1999,
64:
8267
20 Ikariya T.
Ishii Y.
Kawano H.
Arai T.
Saburi M.
Yoshikawa S.
Akutagawa S.
J. Chem. Soc., Chem. Commun.
1985,
922
21 Ohta T.
Tonomura Y.
Nozaki K.
Takaya H.
Mashima K.
Organometallics
1996,
15:
1521
22 Mashima K.
Nakamura T.
Matsuo Y.
Tani K.
J. Organomet. Chem.
2000,
607:
51
23
Typical Procedure for the Synthesis of Ikariya-Mashima’s Catalyst with (
S
)-SYNPHOS
®
10 .2 (η6 -benzene)]2 (25 mg, 0.05 mmol), (S )-SYNPHOS® (64 mg, 0.1 mmol) and dimethylammonium chloride (8 mg, 0.1 mmol) were introduced in a 50 mL round bottom tube equipped with a magnetic stirring bar and a condenser. The mixture was degassed by three vacuum/argon cycles at r.t. Degassed anhyd THF (6 mL) was added. The orange mixture was refluxed overnight and then cooled to r.t. The solvents were evaporated under vacuum and the brown solid 10 was used as crude catalyst for the hydrogenation reaction without further purification.Typical Procedure for the Hydrogenation Reaction with Ikariya-Mashima’s Catalyst 10.
9 (110 mg, 0.30 mmol) in degassed MeOH (2.0 mL) was added to Ikariya-Mashima’s catalyst 10 (6.0 mg, 0.004 mmol) in a round bottom tube via cannula. The reaction vessel was placed in a stainless steel autoclave, which was purged with hydrogen and pressurized to 80 bar. After stirring for 8 h at r.t., hydrogen was vented and the reaction mixture was concentrated in vacuo. The residue was purified by flash chromatography (C6 H12 -EtOAc = 8.5:1.5) to give 11 (102 mg, 0.28 mmol, 93%, de = 98%) as a pale yellow oil.
24 Fürstner A.
Dierkes T.
Thiel OR.
Blanda G.
Chem.-Eur. J.
2001,
7:
5286
25 Blanchette MA.
Choy W.
Davis JT.
Essenfeld AP.
Masamune S.
Roush WR.
Sakai T.
Tetrahedron Lett.
1984,
25:
2183
26 Rychnovsky SD.
Skalitzky DJ.
Tetrahedron Lett.
1990,
31:
945
